Orviglance FDA submission during the summer Good cost control Conf call at 10:00 CEST Recent releva...
Redeye provides an update on Thunderful Group following its Q1 2025 report, which was better than ex...
Redeye updates its estimates and valuation following Navigo releasing its Q1 2025 report.
Q1 below, Q2e slightly better Pulp prices down lately Fair value range of SEK 2-11/share Q1 below, ...
Umida Group (”Umida”, ”koncernen” eller ”bolaget”) publicerade den 15 maj 2025 bolagets delårsrappor...
First Venture (”First Venture” eller ”Bolaget”) publicerade den 15 maj 2025 Bolagets delårsrapport f...
I dag offentliggjorde Angler Gaming (”Angler” eller ”Bolaget”) sin delårsrapport för kv1 2025.
Nosa Plugs AB (“Nosa Plugs” or the “Company”) published the Company’s interim report for the first q...
Redeye provides its first take on Oncopeptides' Q1 report 2025, published this morning.
Redeye comments on Fable Media Group’s Q1 results, which came in weaker than expected.
Redeye provides its first take on Camurus’ Q1 report 2025, published this morning.
Redeye comments on Xspray following yesterday evening’s announcement of a PDUFA date set for early O...
Redeye is bullish about the new results with BI-1808 in cutaneous T-cell lymphoma.
Redeye updates its estimates following Surgical Science’s Q1 2025 report, which beat our projections...
Markets have started turning better Truly decentralised with strong M&A track record Trading at 10x-...
